Christopher Davis Davis Selected Advisers
Christopher Davis is chairman of Davis Advisors, a multi-generational investment firm known for research-intensive equity management. The firm’s strategies often emphasize financials and other businesses where long-term ownership and careful accounting analysis matter. Davis is a frequent public commentator on active management and long-horizon investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PX
Praxair Inc
PX
|
+$473M |
| 2 |
IBM
IBM
|
+$451M |
| 3 |
Ovintiv
OVV
|
+$416M |
| 4 |
UPL
Ultra Petroleum Corp. Common Stock
UPL
|
+$374M |
| 5 |
Amazon
AMZN
|
+$326M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Air Products & Chemicals
APD
|
+$633M |
| 2 |
CVS Health
CVS
|
+$541M |
| 3 |
Costco
COST
|
+$416M |
| 4 |
EOG Resources
EOG
|
+$239M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 39.95% |
| 2 | Communication Services | 11.74% |
| 3 | Healthcare | 11.38% |
| 4 | Consumer Discretionary | 10.17% |
| 5 | Technology | 7.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Visa
V
$693B
| $412M | 1.28% |
7,725,072
+97,032
| +1% | +$5.21M |
|
27
Booking.com
BKNG
$158B
| $412M | 1.28% |
8,887,650
-57,625
| -0.6% | -$2.84M |
|
|
28
Ovintiv
OVV
$18.5B
| $401M | 1.24% |
+3,777,664
| New | +$416M |
|
29
Sysco
SYY
$40.2B
| $400M | 1.24% |
10,527,468
+24,459
| +0.2% | +$913K |
|
30
Loews
L
$22.5B
| $375M | 1.17% |
9,005,737
-2,622,775
| -23% | -$113M |
|
31
Chubb
CB
$132B
| $353M | 1.1% |
3,369,187
+59,329
| +2% | +$6.19M |
|
32
Oracle
ORCL
$422B
| $315M | 0.98% |
8,219,711
-371,078
| -4% | -$15M |
|
33
Quest Diagnostics
DGX
$27B
| $296M | 0.92% |
4,879,416
+206,735
| +4% | +$12.7M |
|
|
ATVI
34
DELISTED
Activision Blizzard
ATVI
| $292M | 0.91% |
14,024,980
-1,398,986
| -9% | -$31.8M |
|
|
QVCGA
35
DELISTED
QVC Group Inc Series A
QVCGA
| $283M | 0.88% |
241,244
-788
| -0.3% | -$932K |
|
36
Brookfield
BN
$93.1B
| $273M | 0.85% |
25,907,719
-1,016,376
| -4% | -$10.9M |
|
37
Berkshire Hathaway Class B
BRK.B
$1.06T
| $264M | 0.82% |
1,908,289
-53,048
| -3% | -$7.07M |
|
38
Walt Disney
DIS
$186B
| $239M | 0.74% |
2,679,895
-157,780
| -6% | -$13.9M |
|
39
Moody's
MCO
$87.2B
| $226M | 0.7% |
2,395,195
-11,062
| -0.5% | -$1.01M |
|
40
Markel Group
MKL
$22.2B
| $219M | 0.68% |
344,882
+15,748
| +5% | +$10.2M |
|
|
MON
41
DELISTED
Monsanto Co
MON
| $208M | 0.65% |
1,848,439
-146,771
| -7% | -$17.2M |
|
42
Textron
TXT
$14.3B
| $185M | 0.57% |
5,128,565
-7,455
| -0.1% | -$280K |
|
43
Netflix
NFLX
$331B
| $182M | 0.57% |
28,271,320
-1,014,440
| -3% | -$6.58M |
|
|
44
CVS Health
CVS
$119B
| $171M | 0.53% |
2,153,905
-6,858,246
| -76% | -$541M |
|
45
Agilent Technologies
A
$44.9B
| $170M | 0.53% |
4,166,406
-16,302
| -0.4% | -$666K |
|
46
Everest Group
EG
$14.2B
| $163M | 0.51% |
1,008,547
-1,730
| -0.2% | -$280K |
|
|
QIHU
47
DELISTED
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
| $149M | 0.46% |
2,209,632
-2,725
| -0.1% | -$243K |
|
|
SFUN
48
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
| $146M | 0.45% |
294,113
+2,991
| +1% | +$1.65M |
|
49
Citizens Financial Group
CFG
$29.4B
| $142M | 0.44% |
+6,062,550
| New | +$141M |
|
50
Diageo
DEO
$52.6B
| $106M | 0.33% |
920,083
-20,359
| -2% | -$2.47M |
|
Similar funds
Christopher Davis's Q3 2014 Portfolio in Review
As of Q3 2014, Christopher Davis held 199 positions worth $32.2B, down 4.3% from $33.6B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Christopher Davis withdrew a net $1.03B in Q3 2014, closing 11 positions and reducing 75 holdings. Its most notable exit was SLB Ltd, an estimated $122M position sold in full.
By sector, the portfolio is most concentrated in Financials at 40% of assets, up from 38% a quarter earlier, followed by Communication Services and Healthcare.
Against the trend, Christopher Davis opened a new position in Ovintiv worth $401M.
- Christopher Davis's largest Q3 2014 buy was Ovintiv: 3,777,664 shares worth $401M.
- Christopher Davis added most to Praxair Inc in Q3 2014, an estimated $473M increase.
- Christopher Davis's biggest Q3 2014 reduction was Air Products & Chemicals, cutting an estimated $633M.
- Christopher Davis fully exited SLB Ltd in Q3 2014, selling an estimated $122M.
- Christopher Davis's ten largest holdings make up 48% of its $32.2B portfolio in Q3 2014.
- Christopher Davis opened 21 new positions and closed 11 in Q3 2014.
- Christopher Davis's portfolio value fell 4.3% quarter-over-quarter to $32.2B.
Based on Davis Selected Advisers's 13F filing for Q3 2014, filed 12 Nov 2014.